Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

FGF21 gene therapy as treatment for obesity and insulin resistance.

Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, Rodó J, Mallol C, Garcia M, León X, Marcó S, Ribera A, Elias I, Casellas A, Grass I, Elias G, Ferré T, Motas S, Franckhauser S, Mulero F, Navarro M, Haurigot V, Ruberte J, Bosch F.

EMBO Mol Med. 2018 Jul 9. pii: e8791. doi: 10.15252/emmm.201708791. [Epub ahead of print]

2.

AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.

Mallol C, Casana E, Jimenez V, Casellas A, Haurigot V, Jambrina C, Sacristan V, Morró M, Agudo J, Vilà L, Bosch F.

Mol Metab. 2017 May 17;6(7):664-680. doi: 10.1016/j.molmet.2017.05.007. eCollection 2017 Jul.

3.

[A comparative study of the marginal non-Gypsy pediatric population].

Sacristán A, García-Rodríguez MA, Coca Palacios C, Sacristán V, Gamarra C, García-García F.

Aten Primaria. 1996 Jul-Aug;18(3):127-30. Spanish.

PMID:
8768656

Supplemental Content

Loading ...
Support Center